Stavridi E S, O'Malley K, Lukacs C M, Moore W T, Lambris J D, Christianson D W, Rubin H, Cooperman B S
Department of Chemistry, School of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
Biochemistry. 1996 Aug 20;35(33):10608-15. doi: 10.1021/bi9605806.
Both human neutrophil elastase (HNE) and free chymotrypsin (Chtr) proteolyze Chtr within the complex that Chtr forms with antichymotrypsin (ACT). As free Chtr is stable both to self-digestion and to digestion by HNE, these results are indicative of a stability and/or conformational change in Chtr that accompanies complex formation. As determined by both N-terminal sequence analysis and matrix-assisted laser desorption ionization mass spectroscopy (MALDI-MS), the major initial sites of HNE cleavage of complexed Chtr are between gamma-chain residues A158/S159 and V188/S189. Significantly, this latter site is at the base of the S1 site that recognizes the P1 position of the serpin. A slower cleavage in the beta-chain between T139/G140 is also found. In addition, rACT is cleaved between residues V22/D23. The gamma-chain of complexed Chtr is also cleaved by free Chtr, but at different sites: L162/L163 and W172/G173. beta-Chain cleavages were also found between residues Q81/K82 and F114/S115. Cleavages similar to those described above were also found when Chtr was complexed with the L358F-rACT variant, but not for Chtr complexed with either of the smaller inhibitors bovine pancreatic trypsin inhibitor or turkey ovomucoid third domain, nor for the covalent adduct of Chtr with N-p-tosylphenylalanyl chloromethyl ketone. We conclude that the structural change in Chtr making it a proteinase substrate is coupled with the large conformational change in ACT following complex formation. Complexed Chtr is much less reactive toward proteolytic digestion in the presence of high salt than in its absence, in accord with the high-salt induced release of active enzyme from the Chtr.rACT complex and the suggestion that electrostatic interactions mediate the coupling of structural change between rACT and Chtr within the Chtr.rACT complex. Potential physiological consequences of this work are explored.
人中性粒细胞弹性蛋白酶(HNE)和游离糜蛋白酶(Chtr)都会在Chtr与抗糜蛋白酶(ACT)形成的复合物中对Chtr进行蛋白水解。由于游离Chtr对自身消化以及HNE的消化均具有稳定性,这些结果表明Chtr在形成复合物时会发生稳定性和/或构象变化。通过N端序列分析和基质辅助激光解吸电离质谱(MALDI-MS)确定,HNE对复合Chtr的主要初始切割位点在γ链残基A158/S159和V188/S189之间。值得注意的是,后一个位点位于识别丝氨酸蛋白酶抑制剂P1位置的S1位点的底部。在β链的T139/G140之间也发现了较慢的切割。此外,重组ACT(rACT)在残基V22/D23之间被切割。复合Chtr的γ链也会被游离Chtr切割,但切割位点不同:L162/L163和W172/G173。在残基Q81/K82和F114/S115之间也发现了β链切割。当Chtr与L358F-rACT变体复合时,也发现了与上述类似的切割,但与Chtr与较小的抑制剂牛胰蛋白酶抑制剂或火鸡卵类粘蛋白第三结构域复合时不同,也与Chtr与N-对甲苯磺酰苯丙氨酰氯甲基酮的共价加合物不同。我们得出结论,Chtr使其成为蛋白酶底物的结构变化与复合物形成后ACT的大构象变化相关联。与不存在高盐时相比,在高盐存在下复合Chtr对蛋白水解消化的反应性要低得多,这与高盐诱导活性酶从Chtr.rACT复合物中释放以及静电相互作用介导Chtr.rACT复合物中rACT和Chtr之间结构变化耦合的观点一致。本文还探讨了这项工作可能产生的生理后果。